Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor

The article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nina A. Petunina, Anna L. Terekhova, Ekaterina V. Goncharova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2016
Materias:
Acceso en línea:https://doaj.org/article/fb4b48718f144cf18d9defcf7341b996
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares